Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (3)
  • 2024 (7)
  • 2023 (11)
  • 2021 (2)

Subject

  • Drug Trafficking (303)
  • Arrests/Convictions - Major (127)
  • Synthetic drugs (73)
  • Fake Pills (41)
  • OCDETF/Task Force (38)
  • Fentanyl Awareness (36)
  • One Pill Can Kill (30)
  • Seizures (Drugs/Property) (24)
  • Guilty Plea (23)
  • Prescription Drugs (20)
  • Money Laundering (18)
  • Take Back Day (15)
  • Guns/Weapons (13)
  • Gangs (12)
  • Major Law Enforcement Operation (11)
  • Outreach/Drug Prevention (11)
  • Pharmaceuticals/Pharmacists/Physicians (11)
  • Overdose (9)
  • Fentanyl Free America (6)
  • Asset Forfeiture (5)
  • Extraditions (4)
  • Press Conferences (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Narcoterrorism (3)
  • Task Forces/Task Force Officers (3)
  • Other (2)
  • Prevention/Education - DEA websites GSAD, JTT etc (2)
  • Campaigns (1)
  • Congressional Affairs (1)
  • HIDTA (1)
  • International/Foreign Operations (1)
  • Scam Calls (1)
  • Terrorism (1)
  • Diversion Division (24)

Drug Name

  • Oxycodone (2)
  • Opioids (1)

Field Division

  • New England (35)
  • Washington, DC (34)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • Sede (10)
  • El Paso (8)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • Houston (16)
  • New Orleans (8)
Clear All Results
24 Results - Showing 1 to 10
PRESS RELEASE

Laredo Pharmacist Pays Six Figures to Settle Controlled Substance Act Violations

HOUSTON – The owner of Martinez Pharmacy in Laredo has agreed to pay $750,000 to resolve allegations his pharmacy violated federal recordkeeping and dispensing requirements, announced Drug Enforcement Administration (DEA) Special Agent in Charge Miguel Madrigal of the San Antonio Division and U.S. Attorney Nicholas J. Ganjei. Antonio Martinez Jr...
PRESS RELEASE

National Health Care Fraud Takedown Results in 324 Defendants Charged in Connection with Over $14.6 Billion in Alleged Fraud

Acting United States Attorney Ellison C. Travis announced criminal charges against two defendants in connection with alleged schemes to defraud government benefit programs. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown. “We are taking significant strides in our ongoing...
PRESS RELEASE

Complaint Filed Against Houston Pharmacy and its Owners for Violations of the Controlled Substances Act

HOUSTON – A civil complaint has been filed seeking monetary penalties against a local pharmacy and its owners following an investigation revealing numerous fraudulent controlled substance prescriptions, announced Acting Special Agent in Charge William Kimbell of the Houston Division and U.S. Attorney Nicholas J. Ganjei. The complaint seeks civil monetary...
PRESS RELEASE

Private Shipping Company to Pay $400,000 to Settle Allegations of Transshipping Fentanyl Precursor Chemicals

SAN ANTONIO – IMC Pro International Inc. has agreed to pay $400,000 to the United States to resolve allegations it violated the Controlled Substances Act through transshipping fentanyl precursor chemicals. The United States alleged IMC Pro International Inc., a North Carolina-based shipping and logistics company, entered business agreements with several...
PRESS RELEASE

San Antonio Man Sentenced to 28 Years in Federal Prison for Armed Pharmacy Robberies

SAN ANTONIO – A San Antonio man was sentenced to 339 months in federal prison for three counts of pharmacy robbery and three counts of brandishing a firearm during and in relation to a crime of violence. According to court documents, from October to December 2020, Atseko Factor, 40, and...
PRESS RELEASE

Multiple Pharmaceutical Distributor Executives, Sales Representatives and Brokers Charged in Connection with Unlawful Sales of over 70M Opioid Pills

HOUSTON - Charges have been unsealed as part of a larger enforcement action related to the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of other commonly abused prescription drugs to alleged Houston-area pill-mill pharmacies. Three Houston-area pharmacy operators were also charged for their role...
PRESS RELEASE

Pharmacy Burglary Conspirators Arraigned Today in Federal Court

LITTLE ROCK—On July 30, 2024, in Houston, Texas, the Drug Enforcement Administration initiated the arrests of twenty-four co-conspirators following a superseding indictment in the Eastern District of Arkansas. The arrests follow the initial indictment and arrest of eighteen people from the Houston, Texas, area in November 2023. Defendants arrested in...
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...
PRESS RELEASE

Samson, Alabama Pharmacy Liable for $110,000 Penalty for Recordkeeping Violations of the Controlled Substances Act

MONTGOMERY, Ala. -- Today, Acting United States Attorney Jonathan S. Ross announced that King Drug Co., Inc. (King Drug), a pharmacy previously doing business in Samson, Alabama, along with owner Traci Revels McCoy, is liable to the United States for $110,000 in civil monetary penalties after failing to comply with...
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster